Kazmierczak Maciej
Publicații indexate în SCOPUS -
![](https://ibn.idsi.md/sites/all/modules/ibn_stats/img/bar_chart.png)
Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia ![]() ![]() |
Robak Tadeusz , Kazmierczak Maciej , Jarque Isidro , Musteaţă Vasile ![]() ![]() |
Blood Advances |
Nr. 4 / 2020 / ISSN 2473-9537 |
Disponibil online 15 March, 2021. Descarcări-0. Vizualizări-497 |